Pharmacology of Antibiotics

  • J. D. Williams
  • A. M. Geddes

Part of the Chemotherapy book series (CT, volume 4)

Table of contents

  1. Front Matter
    Pages i-xiv
  2. Calvin M. Kunin
    Pages 1-5
  3. J. A. Raeburn, E. Watson, E. J. Hanson, T. Johnston
    Pages 17-23
  4. Anna-Stina Malmborg
    Pages 25-33
  5. P.-A. Mårdh, K.-E. Andersson, H. Dencker, M. Åkerlund
    Pages 47-52
  6. Anna-Stina Malmborg, K. Dornbusch, R. Eliasson, C. Lindholmer
    Pages 53-59
  7. J. Verhoef, P. L. Oe
    Pages 85-92
  8. P. L. Oe, J. Verhoef
    Pages 93-100
  9. G. Naumann, M. Holtz, W. Müntner, W. Nimmrich, E. Budde, H. Klinkmann
    Pages 101-105
  10. L. Favalli, M. C. Chiari, A. Rozza, F. Piccinini
    Pages 107-114
  11. G. Kahlmeter, T. Hallberg, S. Jonsson, C. Kamme, B. Ursing
    Pages 115-120
  12. J. L. Anderton, Elizabeth Hanson, J. A. Raeburn
    Pages 121-125
  13. M. Pinget, J. M. Brogard, J. Lavillaureix
    Pages 127-140

About this book


The International Society of Chemotherapy meets every two years to review progress in chemotherapy of infections and of malignant disease. Each meeting gets larger to encompass the extension of chemotherapy into new areas. In some instances, expansion has been rapid, for example in cephalosporins, pen­ icillins and combination chemotherapy of cancer - in others slow, as in the field of parasitology. New problems of resistance and untoward effects arise; reduction of host toxicity without loss of antitumour activity by new substances occupies wide attention. The improved results with cancer chemotherapy, es­ pecially in leukaemias, are leading to a greater prevalence of severe infection in patients so treated, pharmacokinetics of drugs in normal and diseased subjects is receiving increasing attention along with related problems of bioavailability and interactions between drugs. Meanwhile the attack on some of the major bacterial infections, such as gonorrhoea and tubercu­ losis, which were among the first infections to feel the impact of chemotherapy, still continue to be major world problems and are now under attack with new agents and new methods. From this wide field and the 1,000 papers read at the Congress we have produced Proceedings which reflect the variety and vigour of research in this important field of medicine. It was not possible to include all of the papers presented at the Congress but we have attempted to include most aspects of cur­ rent progress in chemotherapy.


cancer chemotherapy kinetics pharmacokinetics research resistance toxicity

Editors and affiliations

  • J. D. Williams
    • 1
  • A. M. Geddes
    • 2
  1. 1.The London Hospital Medical CollegeLondonUK
  2. 2.East Birmingham HospitalBirminghamUK

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag US 1976
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4684-3125-4
  • Online ISBN 978-1-4684-3123-0
  • About this book